Ani Pharmaceuticals Inc (ANIP)
SG&A Expense Growth
24.45%
Quarterly · Period ending:
ANIP SG&A Expense Growth
Latest reported24.45%period ending
Latest reported24.45%period ending
ANIP Quarterly SG&A Growth (QoQ) (0.00% → 24.45%)
Latest values, visible window
High-resolution chart · PNG
ANIP sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 24.4464% | |
| -11.0339% | |
| 8.002% | |
| -6.2553% | |
| 6.8511% | |
| 9.7663% | |
| -11.8318% | |
| 49.7037% | |
| 9.9956% | |
| 8.0046% | |
| 5.8443% | |
| 8.3772% | |
| 6.285% | |
| 9.8831% | |
| 10.3288% | |
| -5.8733% | |
| 10.8998% | |
| -6.1519% | |
| 78.7207% | |
| -8.7088% | |
| 7.0109% | |
| 22.4295% | |
| -8.6486% | |
| -25.8709% | |
| 55.0318% | |
| -2.3619% | |
| -2.3891% | |
| 1.1911% | |
| 6.8052% | |
| -0.6878% | |
| 13.6545% | |
| 18.1389% | |
| 11.2327% | |
| 0.7991% | |
| 10.7579% | |
| 8.6992% | |
| 1.1929% | |
| -1.0313% | |
| 6.3655% | |
| -9.1767% | |
| 29.2005% | |
| 8.231% | |
| 1.0372% | |
| -2.7382% | |
| 16.8386% | |
| 0.1898% | |
| 16.8844% | |
| -25.3267% | |
| 46.7189% | |
| 8.0537% | |
| -3.7688% | |
| -50.8399% | |
| 271.6625% | |
| -32.8311% | |
| 87.5932% | |
| -20.6327% | |
| 6.3948% | |
| 6.2783% | |
| 2.8872% | |
| -15.7777% | |
| 24.8216% | |
| 16.5314% | |
| -10.8788% | |
| -0.3755% | |
| -12.8354% | |
| -8.4145% | |
| 28.1059% | |
| 24.5749% | |
| 17.4654% | |
| -35.8308% | |
| 11.4728% | |
| -9.6877% | |
| 20.1935% | |
| 18.3897% | |
| 8.9962% | |
| -22.4339% | |
| 33.4441% | |
| -68.2257% | |
| 1,383.3557% | |
| -84.1525% | |
| -43.7748% | |
| 178.0284% | |
| 20.5618% | |
| -9.0571% | |
| 7.5891% | |
| -15.0942% | |
| 73.7836% | |
| -34.3018% | |
| -25.6764% | |
| 47.3191% | |
| 41.1025% | |
| -27.6493% | |
| 32.3765% | |
| 25.3101% | |
| -3.1329% | |
| -15.868% | |
| 7.127% | |
| -25.3653% | |
| -14.6147% | |
| 44.679% |